ArticleGenetics and molecular biology2016

Screening for germline BRCA1, BRCA2, TP53 and CHEK2 mutations in families at-risk for hereditary breast cancer identified in a population-based study from Southern Brazil.

Edenir Inêz Palmero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.